Treatment of Warfarin-Associated Intracerebral Hemorrhage: Literature Review and Expert Opinion
- Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. Wilson, S. Jo-Anne; Wells, Philip S.; Kovacs, Michael J.; Lewis, Geoffrey M.; Martin, Janet; Burton, Erica; Anderson, David R. // CMAJ: Canadian Medical Association Journal;8/19/2003, Vol. 169 Issue 4, p293
Background: There is growing evidence that better outcomes are achieved when anticoagulation is managed by anticoagulation clinics rather than by family physicians. We carried out a randomized controlled trial to evaluate these 2 models of anticoagulant care. Methods: We randomly allocated...
- Corrections. // American Family Physician;3/15/2006, Vol. 73 Issue 6, p974
Presents corrections to articles that were previously published in various issues, including "Warfarin Therapy: Evolving Strategies in Anticoagulation."
- Warfarin/herbal medicines interaction. // Reactions Weekly;11/13/2010, Issue 1327, p37
The article describes the case of a man who developed a cerebral haematoma while receiving concomitant therapy with warfarin and shengmaiyin, a Chinese combination herbal product.
- Warfarin interaction. // Reactions Weekly;2/13/2016, Vol. 1588 Issue 1, p261
This article presents a case study of a man in his 30s who diagnosed with intracerebral, intraventricular haemorrhages and cerebral venous thrombosis later developed subtherapeutic international normalized ratio (INR) levels after being treated with warfarin sodium and banana flakes supplement.
- Rate of anticoagulant-associated intracerebral hemorrhage quintuples. // Formulary;Apr2007, Vol. 42 Issue 4, p218
The article discusses the results of the study regarding the case of anticoagulant-associated intracerebral hemorrhage (ICH). According to an observational study published in the journal "Neurology," the rate of anticoagulant-associated ICH has increased since 1988. The case of ICH has been...
- Confronting fears of anticoagulation therapy. Merli, Geno J. // Patient Care;Sep2002, Vol. 36 Issue 11, p8
Discusses how to confront fears of anticoagulation therapy. Factors influencing the safety and effectiveness of anticoagulation; Connection between physician's perceptions of the benefits and risks of warfarin influence on their decision to prescribe anticoagulants; Information on how to deal...
- WARFARIN SODIUM DERIVATIVE: (COUMADINÂ® SODIUM). Shapiro, Shepard // Angiology;Aug1953, Vol. 4 Issue 4, p380
A new hypoprothrombinemia-inducing agent CoumarinÂ® Sodium (warfarin sodium derivative) is described. It is soluble in water and can be administered intravenously. Its characteristics, dosage and the reasons for its advantages over the other 4-hydroxycoumarin anticoagulant drugs now in current...
- Antibacterial prescribing and warfarin: a review. Rice, P J; Perry, R J; Afzal, Z; Stockley, I H // British Dental Journal;4/26/2003, Vol. 194 Issue 8, p411
Warfarin is the most commonly prescribed oral anticoagulant and is used in the management of thromboembolic disease. The practitioner is regularly faced with the need to prescribe concurrent antimicrobial therapy, either as prophylactic cover or in the therapeutic management of existing...
- Patients can self-monitor warfarin. // Pulse;1/15/2005, Vol. 65 Issue 2, p22
This article reports that patients who self-manage their anticoagulation treatment achieve a similar level of control as those who are managed by a doctor and suffer fewer adverse events. The percentage of patients who achieved target INRs was roughly the same in the two groups of patients, at...